MAGELLAN LONGEVITY
HomeResearchStudy library › What are the updated Canadian Cardiovascular Society guidelines for…
Study summary · General aging biology & healthspan

What are the updated Canadian Cardiovascular Society guidelines for perioperative cardiac risk assessment and management in patients undergoing noncardiac surgery?

Can J Cardiol · 2016 · PMID 27865641 · DOI 10.1016/j.cjca.2016.09.008

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

New Canadian guidelines recommend using NT-proBNP before noncardiac surgery for risk assessment and outline specific pre- and post-operative cardiac management strategies.

The question

What are the updated Canadian Cardiovascular Society guidelines for perioperative cardiac risk assessment and management in patients undergoing noncardiac surgery?

What they tested

The Canadian Cardiovascular Society Guidelines Committee and key Canadian opinion leaders believed there was a need for updated guidelines using the GRADE system for perioperative cardiac risk assessment and management.

How they did it

The Canadian Cardiovascular Society Guidelines Committee, along with key Canadian opinion leaders, developed updated guidelines using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system of evidence assessment.

What they found

Strong recommendations were made for: 1) measuring BNP or NT-proBNP before surgery in specific patient groups; 2) against several preoperative cardiac tests; 3) against routine acetylsalicylic acid for perioperative cardiac event prevention, with exceptions; 4) against initiating α-agonist or β-blocker within 24 hours before surgery; 5) withholding ACE inhibitor and ARB starting 24 hours before surgery; 6) facilitating smoking cessation before surgery; 7) measuring daily troponin for 48-72 hours after surgery in specific patient groups; and 8) initiating long-term acetylsalicylic acid and statin therapy in patients with postoperative myocardial injury/infarction.

What it means

The updated Canadian Cardiovascular Society guidelines provide strong recommendations for perioperative cardiac risk estimation and management, including the use of natriuretic peptides and specific interventions, while advising against certain common practices.

Limitations

The abstract does not explicitly state any limitations of the guideline development process or the recommendations themselves.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“measuring NT-proBNP before surgery enhances perioperative cardiac risk estimation”— from the published abstract, Can J Cardiol 2016

The paper at a glance

Magellan’s evidence labelNT-proBNP natriuretic peptide (our label for this citation — see PubMed for the paper’s own title and authors)
JournalCan J Cardiol
Year2016
PMID27865641 ↗
DOI10.1016/j.cjca.2016.09.008 ↗
TopicGeneral aging biology & healthspan

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

NT-proBNP Cardiac Test

Improves cardiovascular risk estimation. Research relevant to this mechanism is indexed on PubMed and linked below; it describes the mechanism rather than this specific product.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What are the updated Canadian Cardiovascular Society guidelines for perioperative cardiac risk assessment and management in patients undergoing noncardiac surgery? [Plain-English summary of Can J Cardiol 2016, PMID 27865641, DOI 10.1016/j.cjca.2016.09.008]. Magellan Longevity. https://magellanlongevity.com/study/s158.html
BibTeX
@misc{magellan_s158, title = {What are the updated Canadian Cardiovascular Society guidelines for perioperative cardiac risk assessment and management in patients undergoing noncardiac surgery?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s158.html}}, note = {Plain-English summary of PubMed PMID 27865641; DOI 10.1016/j.cjca.2016.09.008; Can J Cardiol 2016. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s158.html

Related studies in the Magellan library

All 25 Magellan summaries on general aging biology & healthspan →

How this summary was made. Every section above restates what the published abstract of PMID 27865641 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.